Metabolic inference from genomic sequence information is a necessary step in determining the capacity of cells to make a living in the world at different levels of biological organization. A common method for determining the metabolic potential encoded in genomes is to map conceptually translated open reading frames onto a database containing known product descriptions. Such gene-centric methods are limited in their capacity to predict pathway presence or absence and do not support standardized rule-sets for automated and reproducible research. Pathway-centric methods based on defined rule sets or machine learning algorithms provide an adjunct or alternative inference method that supports hypothesis generation and testing of metabaolic relationships within and between cells. Here, we present mlLGPR, multi-label based on logistic regression for pathway prediction, a software package that uses supervised multi-label classification and rich pathway features to infer metabolic networks at the individual, population and community levels of organization. We evaluated mlLGPR performance using a corpora of 12 experimental datasets manifesting diverse multi-label properties, including manually curated organismal genomes, synthetic microbial communities and low complexity microbial communities. Resulting performance metrics equaled or exceeded previous reports for organismal genomes and identify specific challenges associated with features engineering and training data for community-level metabolic inference.
biotechnological applications. A pathway prediction problem exists because we have limited knowledge of the reactions and pathways operating in cells even in model organisms like Esherichia coli where the majority of protein functions are determined. To improve pathway prediction outcomes for genomes at different levels of complexity and completion we have developed mlLGPR, multi-label based on logistic regression for pathway prediction, a scalable open source software package that uses supervised multi-label classification and rich pathway features to infer metabolic networks. We benchmark mlLGPR performance against other inference methods providing a code base and metrics for continued application of machine learning methods to the pathway prediction problem at the individual, population and community levels of biological organization. Genomic information hierarchy encompassing individual, population and community levels of cellular organization. (a) Building on the BioCyc curation-tiered structure of Pathway/Genome Databases (PGDBs) constructed from organismal genomes, two additional data structures are resolved from single-cell and plurality sequencing methods to define a 4 tiered hierarchy (T1-4) in descending order of manual curation and functional validation. (b) Completion scales for organismal genomes, single-cell amplified gemomes (SAGs) and metagenome assembled genomes (MAGs) within the 4 tiered information hierarchy. Genome completion will have a direct effect on metabolic inference outcomes with incomplete organismal genomes, SAGs or MAGS resolving fewer metabolic interactions. Pathway/Genome Databases (ePGDBs) representing community level metabolic models 40 e.g. T4 on the information hierarchy in (Fig 1) [ [13] [14] [15] that can also be stored in open 41 source repositories e.g. EngCyc or GutCyc [14, 16] . 42 While Pathologic provides a powerful engine for pathway-centric inference, it is a 43 hard coded and relatively inflexible application that does not not scale efficiently for 44 community sequencing projects. Moreover, Pathologic does not provide probability 45 scores associated with inferred pathways further limiting its statistical power with 46 respect to false discovery. An alternative inference method called MinPath uses integer 47 programming to identify the minimum number of pathways that can be described given 48 a set of defined input sequences e.g. KO family annotations in KEGG [17] . However, 49 such a parsimony approach is prone to false negatives and can be difficult to scale. Pathway Tools [9] , and alternative methods for pathway-centric inference expanding on 63 the algorithms evaluated by Dale and colleagues remain nascent. Several recent efforts 64 incorporate metabolite information to improve pathway inference and reaction rules to 65 infer metabolic pathways [3, [19] [20] [21] . Others, including BiomeNet [22] and 66 MetaNetSim [23] omit pathways and model reaction networks based on enzyme 67 abundance information. Here we describe a multi-label classification approach to 68 metabolic pathway inference using rich pathway feature information called mlLGPR, 69 multi-label based on logistic regression for pathway prediction. mlLGPR uses logistic 70 regression and feature vectors based on the work of Dale and colleagues to predict 71 metabolic pathways for individual genomes as well as more complex cellular 72 communities e.g. microbiomes. We evaluate mlLGPR performance in relation to other 73 inference methods including Pathologic and MinPath on a set of T1 PGDBs alone and 74 in combination from the BioCyc collection, symbiont genomes encoding distributed 75 metabolic pathways for amino acid biosynthesis [24] , genomes used in the Critical
76
Assessment of Metagenome Interpretation (CAMI) initiative [25] , and whole genome 77 shotgun sequences from the Hawaii Ocean Time Series (HOTS) [26] .
78
The mlLGPR Method
79
In this section, we provide a series of definitions and the problem formulation followed 80 by a description of mlLGPR components including: i)-features representation, ii)-the 81 prediction model, and iii)-the multi-label learning process. mlLGPR was written in 82 Python v3 and depends on scikit-learn v0.20 [27] , Numpy v1.16 [28] , NetworkX 83 v2.3 [29] , and SciPy v1.4 [30] .
84

Definitions and Problem Formulation
85
Here, the default vector is considered to be a column vector and is represented by a 86 boldface lowercase letter (e.g., x) while the matrix of it is denoted by boldface uppercase 87 letter (e.g., X). If a subscript letter i is attached to a matrix, such as x (i) , it indicates 88 the i-th row of X, which is a row vector while a subscript character to a vector, Φ : X → R m , which can be described as a feature extraction and transformation process 107 (see Section Features Engineering). Given the above notation and a multi-label dataset 108 S, we want to learn a hypothesis function f : Φ(x) → 2 |Y| from S, such that it predicts 109 metabolic pathways in new samples as accurately as possible. The design of feature vectors is critical for accurate classification and pathway inference. 112 We consider five types of feature vectors based on the work of Dale and colleagues [18] : 
where y (i) j is the j-th element of the label vector y (i) ∈ {0, 1} t and θ j is a 137 m-dimensional weight vector for the j-th pathway. Each element of Φ(x (i) ) corresponds 138 to an element of θ j for the j-class, therefore, we can retrieve important features that 139 contribute to the prediction of j by sorting the elements of Φ(x (i) ) according to the 140 corresponding values of the weight vector θ j . The Eq 1 is repeated for all the t classes 141 for an instance i, hence multi-labeling, and, for an individual pathway, the results are 142 stored in a vector q (i) ∈ R t . Predicted pathways are reported based on a cut-off 143 threshold τ , which is set to 0.5 by default:
where vec is a vectorized operation. Given that Eq 1 produces a conditional 145 probability over each pathway, and the j-th class label will be included to y (i) only if 146 f (θ j , Φ(x (i) )) ≥ τ we adopt a soft decision boundary using T-criterion rule [33] as:
where f max (f (θ j , Φ(x (i) ))) = β · max {f (θ j , Φ(x (i) ) : ∀j ∈ t} , which is the 148 maximum predictive probability score. The hyper-parameter β ∈ (0, 1] must be tuned 149 based on empirical information, and it cannot be set to 0, which implies retrieving all of 150 the t pathways. The predicted set of pathways using the Eq 3 is referred to as adaptive 151 prediction because the decision boundary, and its corresponding threshold, are tuned to 152 the test data [34] .
153
Multi-Label Learning Process
154
The process is decomposed into t independent binary classification problems, where 155 each binary classification problem corresponds to a possible pathway in the label space. 156 Then, LR is used to define a binary classifier f (.), such that for a training example features is high. Thus, the overall objective cost function (after dropping the maximized 163 term for brevity) is defined as:
where λ > 0 is a hyper-parameter that controls the trade-off between ll (θ j ) and
165 Ω(θ j ). Here, the regularization term Ω(θ j ) is chosen to be the elastic net:
166
The elastic net penalty of Eq 6 is a compromise between the L 1 penalty of LASSO 167 (by setting α = 1) and the L 2 penalty of ridge-regression (by setting α = 0) [35] . While 168 the L 1 term of the elastic net aims to remove irrelevant variables by forcing some 169 coefficients of θ j to 0, leading to a sparse vector of θ j , the L 2 penalty ensures that 170 highly correlated variables have similar regression coefficients. Substituting Eq 6 into 171 Eq 5, yields the following objective function:
During learning, the aim is to estimate parameters θ j so as to maximize C(θ j ), 173 which is convex; however, the last term of Eq 7 is non-differentiable, making the 174 equation non-smooth. For the rightmost term, we apply the sub-gradient [36] method 175 allowing the optimization problem to be solved using mini-batch gradient descent 176 (GD) [37] . We initialize with random values for θ j , followed by iterations to maximize 177 the cost function C(θ j ) with the following derivatives:
Finally, the update algorithm for θ j at each iteration is obtained as:
where u is the current step. The mathematical derivation of the algorithm can be found 180 in Supplemental S1 Appendix.
181
Experimental Setup
182
In this section, we describe an experimental framework used to demonstrate mlLGPR 183 pathway prediction performance across multiple datasets spanning the genomic 184 information hierarchy (Fig 1) . [26] . More 201 information about the datasets are summarized in Supplementary S3 Appendix.
202
mlLGPR performance was compared to four additional prediction methods including 203 Baseline, Naïve v1.2 [17] , MinPath v1.2 [17] and PathoLogic v21 [10] . In the baseline 204 method, the enzymatic reactions of x (i) for an instance i are mapped directly onto the 205 true representation of all known pathways Y. In the Naïve method, reactions are 206 randomly predicted from MetaCyc and linked together to construct pathways that are 207 accepted or rejected based on a specified cut-off threshold, typically set to 0.5. If one or 208 more enzymatic reactions are assigned to a pathway then that pathway is identified as 209 present; otherwise, it is rejected. MinPath recovers the minimal set of pathways that 210 can explain observed enzymatic reactions through an iterative constrained optimization 211 process using an integer programming algorithm [38] . PathoLogic uses a rule-based 212 approach to metabolic inference incorporating manually curated biochemical 213 information in a two step process that first produces a reactome that is in turn used to 214 predict metabolic pathways within a PGDB [10] . 215 For training purposes Synset-1 and Synset-2, where subdivided in three subsets:
216
(training set, validation set, and test set), using a stratified sampling approach [39] The following metrics were used to report on performance of prediction algorithms used 230 in the experimental framework outlined above: average precision, average recall, average 231 F1 score (F1), and Hamming loss, [40] . 232 Formally, let us denote y (i) and y (i) to be the true and the predicted pathway set for 233 the i-the sample, respectively. Then, the four measurements can be defined as:
Average F1 = 2Pr × Rc Pr + Rc (12) Hamming Loss (hloss) = 1 nt that are incorrectly predicted providing a useful performance indicator. From Eq 13, we 245 observe that when all of the pathways are correctly predicted, then hloss = 0, whereas 246 the other metrics will be equal to 1. On the other hand, when the predictions of all 247 pathways are completely incorrect hloss = 1, whereas the other metrics will be equal to 248 0.
249
Results
250
Four types of analysis including parameter sensitivity, features selection, robustness, 251 and pathway prediction potential were used to tune and evaluate mlLGPR performance 252 in relation to other pathway prediction methods. 
298
Experimental results. Table 3 indicates ablation test results. The AB feature set 299 promotes the highest average recall on EcoCyc (0.9511) and a comparable F1-score of 300 0.6952. This is not unexpected given the ratio of pathways to the number of enzymatic 301 reactions (PLR) indicated by EC numbers for EcoCyc is high. However, although 302 functional annotations with EC numbers increase the probability of predicting a given 303 pathway, pathways with few or no EC numbers such as pregnenolone biosynthesis Experimental setup. robustness also known as accuracy loss rate was determined for 320 mlLGPR-EN with AB, RE and PE feature sets using the intact Synset-1 dataset and a 321 "corrupted" or noisy version of the Synset-2 dataset. Relative Loss of Accuracy (RLA) 322 and equalized loss of accuracy (ELA) scores [42] were used to describe the expected Experimental results. Table 5 shows performance scores for each pathway prediction 349 method tested. The BASELINE, Naïve, and MinPath methods infer many false positive 350 pathways across the T1 golden datasets, indicated by high recall with low precision and 351 resulting amino acid biosynthetic pathway distributions were determined ( Fig 5) . Additional feature information restricting the taxonomic range of certain pathways or 371 more restrictive pathway coverage could reduce false discovery on individual organismal 372 genomes.
373
To evaluate pathway prediction performance of mlLGPR-EN on more complex 374 Fig 5. Predicted pathways for symbiont datasets between mlLGPR-EN with AB, RE and PE feature sets and PathoLogic. Red circles indicate that neither method predicted a specific pathway while green circles indicate that both methods predicted a specific pathway. Blue circles indicate pathways predicted solely by mlLGPR. The size of circles scales with reaction abundance information.
community-level genomes the CAMI low complexity and HOTS datasets were selected. 375 Table 2 in Supplementary S3 Appendix shows performance scores for mlLGPR-EN on 376 the CAMI dataset. Although recall was high (0.7827) precision and F1 scores were low 377 when compared to the T1 golden datasets. Similar results were obtained for the HOTS 378 dataset (data not shown). In both cases it is difficult to validate most pathway 379 prediction results without individual organismal genomes that can be replicated in while on the other they present numerous opportunities for hypothesis generation and 384 testing. To better constrain this tension, mlLGPR-EN and Pathologic prediction results 385 were compared for a subset of 39 pathways previously reported in the HOTS 386 dataset [14] . Fig 6 shows pathway distributions spanning sunlit and dark ocean waters 387 predicted by PathoLogic and mlLGPR-EN, grouped according to higher order functions 388 within the MetaCyc classification hierarchy. Between 25 and 500 m depth intervals, 7 389 pathways were exclusively predicted by PathoLogic and 6 were exclusively predicted by 390 mlLGPR-EN. Another 20 pathways were predicted by both methods, while 6 pathways 391 were not predicted by either method including glycine biosynthesis IV, thiamine 392 diphosphate biosynthesis II and IV, flavanoid biosynthesis, 2-methylcitrate cycle II and 393 L-methionine degradation III. In several instances, the depth distributions of predicted 394 pathways were also different from those described in [14] 
